Primary, secondary, and catastrophic antiphospholipid syndrome: what's in a name?

Seminars in Thrombosis and Hemostasis
E Nigel Harris, Silvia S Pierangeli

Abstract

The association of the lupus anticoagulant with thrombosis and recurrent pregnancy loss was first recognized over a 20-year period between the early 1960s and early 1980s. The introduction of the anticardiolipin test in 1983 and the recognition of its association with clinical features similar to the lupus anticoagulant led to an exponential growth of interest in this disorder. The belief that anticardiolipin antibodies and lupus anticoagulant belonged to the family of antiphospholipid antibodies led to the disorder being named the antiphospholipid syndrome (APS). Efforts by individual investigators to introduce criteria for classification of APS and to standardize anticardiolipin antibody and lupus anticoagulant tests were started in the mid-1980s to ensure more reliable recognition and treatment of affected patients. Another layer of complexity was introduced with recognition that many anticardiolipin antibody-positive sera also bound the antigen beta (2) glycoprotein I. With increasingly sophisticated epidemiologic and prospective studies in the 1990s, more structured and better-documented criteria for APS were introduced in 1999 and modified in 2006. These criteria have been widely adopted. Whereas data supporting subclassi...Continue Reading

Citations

Dec 5, 2008·Clinical Reviews in Allergy & Immunology·Ljudmila StojanovichNikola Milinic
Apr 7, 2011·Current Opinion in Pediatrics·Andrew I Shulman, Marilynn Punaro
Feb 1, 2011·Clinical Chemistry and Laboratory Medicine : CCLM·Emmanuel J Favaloro, Richard C W Wong
Jan 28, 2009·Current Rheumatology Reports·Debbie A Gladd, Ewa Olech
Mar 29, 2012·Autoimmune Diseases·Adriana Rojas-VillarragaJuan-Manuel Anaya
Apr 18, 2014·Journal of Immunology Research·Raquel Ruiz-GarcíaAntonio Serrano
Apr 16, 2015·International Journal of Immunopathology and Pharmacology·S CaporuscioG Pranteda
Oct 31, 2018·Transplantation·Jose Maria MoralesAntonio Serrano
Nov 2, 2016·Clinical Chemistry and Laboratory Medicine : CCLM·Markus A ThalerPeter B Luppa
May 1, 2010·Auto- Immunity Highlights·Emmanuel J Favaloro, Richard C W Wong
Mar 13, 2015·Current Rheumatology Reports·Rohan WillisA R Brasier
Feb 13, 2018·Frontiers in Medicine·Vítor Teixeira, Lai-Shan Tam
Jul 21, 2016·International Journal of Laboratory Hematology·D PérezA Serrano
Jul 11, 2016·Antibodies·José A Martínez-FloresAntonio Serrano

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Related Papers

The New England Journal of Medicine
Jerrold S LevineJoyce Rauch
Seminars in Thrombosis and Hemostasis
Anita Palatinus, Murray Adams
© 2022 Meta ULC. All rights reserved